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ARTICLE
CREB controls cortical circuit plasticity and
functional recovery after stroke
L. Caracciolo1, M. Marosi1,2, J. Mazzitelli1, S. Latifi1, Y. Sano2,3,4,5,6, L. Galvan4, R. Kawaguchi7,8, S. Holley4,
M.S. Levine4, G. Coppola 7,8, C. Portera-Cailliau1,2, A.J. Silva2,3,4,5,6 & S.T. Carmichael 1,2
Treatments that stimulate neuronal excitability enhance motor performance after stroke.
cAMP-response-element binding protein (CREB) is a transcription factor that plays a key role
in neuronal excitability. Increasing the levels of CREB with a viral vector in a small pool of
motor neurons enhances motor recovery after stroke, while blocking CREB signaling prevents
stroke recovery. Silencing CREB-transfected neurons in the peri-infarct region with the
hM4Di-DREADD blocks motor recovery. Reversing this inhibition allows recovery to
continue, demonstrating that by manipulating the activity of CREB-transfected neurons it is
possible to turn off and on stroke recovery. CREB transfection enhances remapping of injured
somatosensory and motor circuits, and induces the formation of new connections within
these circuits. CREB is a central molecular node in the circuit responses after stroke that lead
to recovery from motor deficits.
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Stroke is the leading cause of adult disability because of thebrain’s limited capacity to repair1. Approaches that increaseneuronal excitability, such as anodal direct current
stimulation or transcranial magnetic stimulation, enhance motor
performance after stroke2–6. In rodent models of stroke,
pharmacogenetic treatments that enhance neuronal excitability in
peri-infarct cortex adjacent to the stroke also promote motor
recovery7,8. These data in humans and rodent models of stroke
support the concept that enhancing neuronal excitability in
motor circuits ipsilateral to the stroke may increase the function
in these partially damaged areas and therefore promote recovery.
The transcription factor cAMP-response-element binding
protein (CREB) enhances long-term synaptic plasticity and
increases neuronal excitability9–12. Viral CREB transduction in
neurons boosts baseline firing rate and the formation of long-
term potentiation (LTP)10–12. CREB also plays a role in cortical
remapping to environmental alterations13,14. In these functions,
CREB increases spine density in neurons5,15, altering local
neuronal connectivity. Interestingly, stroke recovery is associated
with dramatic spine plasticity in the peri-infarct cortex, with an
increase in spine density over baseline values in some regions6.
These data indicate that CREB-dependent transcription has a
critical role in the modulation of neuronal excitability and in
long-lasting alterations in circuit structure during cortical
plasticity and memory. We hypothesized that CREB function in a
localized network of motor cortical neurons near the stroke site
might enhance motor recovery by facilitating remapping of local
cortical networks.
Results
CREB in a pool of neurons induces recovery after stroke. To
determine the role of CREB in motor recovery after stroke, we
increased its expression in a small pool of neurons in motor and
premotor cortex anterior to the site of the stroke (Fig. 1a, b;
Supplementary Fig. 1). A photothrombotic stroke was produced
in the forelimb motor cortex. This model produces long-lasting
behavioral deficits in motor function8,16–20 in which motor and
premotor sites play a causal role in motor recovery17–20. In this
lentiviral gene delivery, CREB-eGFP expression is under the
regulation of the excitatory neuron-specific αCaMKII promoter
along with enhanced green fluorescent protein (CaMKIIa_HA/
AlstR_CREB/eGFP, referred as lenti-CREB; Fig. 1c). Control
virus was eGFP/tdTomato (CamkIIa_HA/AlstR_eGFP/tdTo-
mato; Fig. 1e). Unlike adeno-associated virus (AAV), lentivirus
produces a restricted column of transfected cortical neurons
(Fig. 1c). Stereological quantification shows that lentiviral CREB
expression is present in 8884 ± 2753 neurons in the motor cortex
(Fig. 1d). Consistent with the specificity of the αCaMKII pro-
moter, there was no co-localization of lentivirus-CREB with
markers of inhibitory neurons (glutamate decarboxylase 67;
GAD67) or astrocytes (glial fibrillary acidic protein; GFAP)
(Fig. 1f; Supplementary Figs. 2–4). Thus, this approach increases
the expression of wild-type CREB, delivering a gain of function in
a tightly circumscribed region of motor cortex adjacent to the
stroke site, corresponding to roughly 16% of all neurons in motor
cortex (total neuronal nuclei (NeuN) positive neurons: 57,000 ±
7900; Fig. 1d). This lentivirus-CREB approach increases neuronal
excitability (Supplementary Fig. 5).
Lentivirus was injected immediately after cortical stroke,
expressing detectable CREB levels approximately 7 days after
the stroke (Fig. 1c; Supplementary Figs. 1–4). Behavioral
performance in motor control was measured over 12 weeks in
grid-walking, pasta-handling (capellini test), and cylinder tests
(Fig. 2a; Supplementary Figs. 6–9). These tasks measure the
pattern of movement of the limbs of animals during locomotion,
skilled forelimb use, and in exploratory forelimb use, respec-
tively20–22. Stroke impairs motor control in all three tasks (Fig. 2a;
Supplementary Figs. 5–9). In stroke control virus, recovery was
observed only by 12 weeks in grid walking (Stroke control virus vs
Stroke CREB; 4 weeks: ***P < 0.001; 8 weeks: **P < 0.005;
F (3, 160)= 19.90), while there was still a persistent deficit in
the pasta-handling task (Stroke control virus vs Stroke CREB;
3 weeks: ****P < 0.0001, 5 weeks: ****P < 0.0001, F (3, 160)=
36.26; Fig. 2b, c). Moreover, we observed that mice with stroke
continued to use the non-affected forelimb (left paw) in the
cylinder task over 12 weeks after stroke (P= 0.0008, F (3, 170)=
5.799; Supplementary Fig. 6). Remarkably, lenti-CREB delivery to
a pool of motor cortical neurons anterior to the stroke site
significantly improves functional recovery of motor control
within 3–4 weeks in grid and pasta handling tasks (grid-walking:
4 weeks ***P < 0.001, F (3, 160)= 19.90; pasta handling: 3 weeks
****P < 0.0001, F (3, 160)= 36.26; Fig. 2b, c). An improvement in
forelimb use with lenti-CREB also occurs in the cylinder task even
though not statistically significant (Supplementary Fig. 6).
To further evaluate the role of CREB in stroke recovery, this
experiment was repeated in a larger stroke model, which involves
the striatum, subcortical white matter, and cortex (Supplementary
Fig. 11a, b). Viral delivery and behavioral testing were as for the
cortical stroke model, except only gridwalking and pasta handling
were tested because of the variability of the cylinder task. The
behavioral deficits are worse in this larger stroke, and there is
little recovery after months from the infarct in both gridwalking
and pasta handling (Supplementary Fig. 11c, d). Beginning at
7 weeks in pasta handling (F (2, 111)= 22.44; P < 0.0012) and at
11 weeks in gridwalking (F (2, 124)= 41.63; P < 0.0093), there is a
significant improvement in motor performance in lenti-CREB
compared to stroke+ control virus. In all stroke behavioral
studies, cortical and subcortical stroke and in the ligand binding
domain (LBD) CREB loss of function stroke model (below), there
is no difference in stroke size across CREB and control conditions
(Supplementary Fig. 11e–h). These studies show that CREB
induction in a small pool of excitatory motor cortical neurons is
sufficient to accelerate functional motor recovery of the
contralateral forelimb after stroke in two different stroke models.
CREB-induced recovery is specific to the neuronal circuits with
CREB-transfected cells in motor cortex anterior to the stroke, as
lenti-CREB injection into cortex at a corresponding site
immediately posterior to the stroke lesion (posterior parietal
association area, PTLp22) does not enhance motor recovery after
stroke, indicating the selective nature of CREB function in peri-
infarct motor cortical neurons (Fig. 2d, e; Supplementary Fig. 7).
Motor recovery in this and other rodent stroke models occurs
spontaneously. During behavioral testing, such as walking on the
challenging grid, mice make initial mistakes in the testing time
epoch and then improve their performance (Supplementary
Fig. 9). To determine if CREB plays a role in this process of motor
learning during spontaneous recovery after stroke, we used the
LBD-inducible system to temporally and reversibly repress CREB
function using Tamoxifen (TAM)23, TAM delivery disrupts
memory consolidation in contextual fear conditioning tasks with
a tight temporal window 6–12 h before the conditioning
stimulus23. LBD-CREB mice were administered TAM or vehicle
(saline) 6 h before behavioral testing. Blockade of CREB signaling
immediately prior to motor testing in mice prevented the time-
dependent improvement in performance in grid-walking and
reduced the overall level of motor performance. (Fig. 2f;
Supplementary Fig. 8). Stroke in LBD-CREB mice in which
TAM is administered prior to testing shows that motor recovery
does not improve over the course of the post-stroke period, up to
2 months (Fig. 2f). Inhibiting CREB in the LBD-CREB mice
immediately before motor testing reduces the motor performance
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in gait testing, such that LBD-CREB mice given TAM prior to
testing show a flat recovery curve and persistent motor control
deficit in grid walking (Fig. 2f; Supplementary Fig. 9). CREB
inhibition produced a trend toward worse motor performance in
pasta-handling (Fig. 2g; Supplementary Fig. 8). Overall, these data
indicate that CREB gain of function improves motor recovery
after stroke, that this is specific to motor cortical circuits adjacent
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Fig. 1 Lentiviral CREB expression in cortical pyramidal neurons. a Schematic shows location of stroke area (red) and two lentivirus injections (green) in the
peri-infarct area. b Atlas-based22 schematic of location of lentivirus injection (green) and stroke (red). c Left: Lenti-CREB-eGFP in peri-infarct cortex at the
time of stroke, 7 days after injection and after stroke induction. Transfected cells form a column in cortex. Top is the pial surface, bottom is the white
matter. Scale bar= 300 μm. Right panels: CREB-eGFP staining (green, infected cell) in peri-infarct tissue, co-localize with NeuN staining (orange) 4 weeks
after stroke. Scale bar= 50 μm. d Stereological quantification of motor cortex CREB-induced cells (CREB-eGFP+ cells) relative to the whole motor cortex
neuronal pool (NeuN+ cell ± SEM). n= 4 (eight brain sections for each mouse). e Immunohistochemical staining in peri-infarct M1 in mice transfected with
control virus (green, tdtomato-eGFP) overlapping with NeuN staining (orange) 4 weeks after stroke. Scale bar= 50 μm. f Left: immunohistochemical
staining in peri-infarct M1 in mice transfected with Lenti-Creb-eGFP (green) overlapping with NeuN staining (purple); Middle: immunohistochemical
staining showing inhibitory neurons (GAD67, glutamate decarboxylase 67); Right: immunohistochemical staining showing that there are very rare Lenti-
CREB infected cells that double stain for GAD67, 4 weeks after stroke. Scale bar= 100 μm. M1 primary motor cortex, M2 secondary motor cortex, S1
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to the stroke site, and that CREB loss of function inhibits motor
control after stroke.
Switching on or off recovery of motor function after stroke. To
directly test the role of CREB-expressing neurons in motor
recovery, we selectively inactivated the neurons in motor cortex
with lentivirus expressed-CREB. Viruses were transfected into
motor cortex anterior to the stroke as in the previous experi-
ments. In these experiments, however, we included the hM4Di
DREADD receptor to inducibly inactivate these neurons24
(hM4Di/CREB, Fig. 3a, b). We also included several controls.
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First, to control for the CREB effect, a cohort of mice received the
same viral construct with only hM4Di (no CREB: referred to as
hM4Di, Supplementary Fig. 9). Also, cohorts of mice received
hM4Di/CREB but did not receive the hM4Di ligand (Clozapine-
N-Oxide, CNO) in both stroke and control groups, to control for
the effect of CNO. Stereological quantification shows that these
viruses transfect 7100 ± 2070 neurons in motor cortex (Fig. 3b),
similar to the original lenti-CREB constructs (Supplementary
Fig. 3).
Mice received injections of lenti-CREB+ hM4Di or hM4Di
alone at the time of stroke. As with the previous experiments,
these viruses express protein beginning at one week after injection
so that the effect is tested during stroke recovery and not in the
acute phase of stroke cell death. CNO administration to mice with
hM4Di/CREB reduces the immediate early genes Zif268 and
phospho-Creb (pCREB) as measured stereologcially, co-localized
with viral transfection, indicating a significant reduction in
neuronal activation in cells in which hM4Di is expressed (**P <
0.005 and ***P < 0.001, respectively, Student’s t-test; Fig. 3c). Mice
were tested behaviorally over 12 weeks after stroke (Fig. 3d–i).
Saline or CNO was delivered 30 min before each behavioral test.
This strategy selectively inactivates neurons in motor cortex just
prior to behavioral testing.
As shown above, with the CREB lentivirus (saline adminis-
tration), overexpression of CREB with the hM4Di/CREB vector
(but no CNO) enhances motor recovery in stroke. hM4Di/
CREB saline mice demonstrate greater control and faster speed
in eating pasta, a reduction in the number of foot faults in grid-
walking, improved gait, and preference for the right (affected)
paw in exploratory forelimb use in cylinder task starting at
4 weeks after stroke (****P < 0.0001, F (5, 300)= 98.15; Fig. 3d,
e, Supplementary Fig. 9). These results replicate the earlier
findings that lentivirus induction of CREB enhances motor
recovery (Fig. 2b, c).
Importantly, inactivating CREB-transfected cells with CNO
blocks the improved motor control in recovery after stroke. Mice
with hM4Di/CREB+ CNO-stroke perform significantly worse in
gait, skilled pasta handling and affected forelimb use in rearing
than saline controls (****P < 0.0001, F (5, 372)= 63.86; Fig. 3f, g,
Supplementary Fig. 9). The poor motor control is particularly
noticeable in the grid walking task, in which hM4Di/CREB mice
when given CNO prior to testing commit roughly twice as many
foot-faults compared to stroke-alone or stroke+ hM4Di+CNO
(no CREB) (Fig. 3f). In the pasta handling task, both groups of
mice in which CREB is induced (with stroke and in non-stroke)
perform worse than stroke+ hM4Di+ CNO (****P < 0.0001, F
(5, 372)= 63.86; Fig. 3g, Supplementary Fig. 10), indicating that
inhibition of CREB transduced neurons causes a worse motor
deficit than inhibition of a similar number of neurons without
CREB induction. These data indicate that acute inactivation of
CREB-transfected motor cortical neurons after stroke does not
just block the normal recovery of motor performance after stroke,
but causes a marked deterioration of limb control that is much
greater than that produced by stroke-alone. The results suggest
that CREB-expressing neurons are preferentially incorporated
into stroke recovering circuits, a result consistent with studies
that demonstrated that CREB-expressing neurons are preferen-
tially incorporated into memory engrams24–26.
Accordingly, inactivation of CREB-expressing neurons in the
non-stroke groups caused a significant deficit in motor control in
pasta handling and grid-walking (Fig. 2b) compared with mice
transfected with viral vectors with hM4Di but without CREB
(****P < 0.0001, F (5, 372)= 63.86; ****P < 0.0001, F (5, 372)=
63.86; Fig. 3f, g, Supplementary Fig. 10). The degree of motor
deficit triggered by inactivation of CREB-expressing neurons in
the normal brain is similar to that observed after stroke. Again,
this impairment is not seen after inactivation of cells transfected
with viral vectors that do not include CREB (Fig. 3f, g). Also,
DREAD-induced inactivation of motor cortical neurons alone
does not impair motor control (Supplementary Fig. 12), indicat-
ing that it is first the induction of CREB, inducing circuit
plasticity, and then the acute inactivation of CREB-induced
neurons that produces deficits in motor control (non-stroke) or
the recovered motor function (stroke).
Altogether, these experiments indicate that inactivating a pool
of excitatory motor cortical neurons (15% of the motor cortex)
with hM4Di has no observable effect on motor performance
(Fig. 3b; Supplementary Fig. 12). However, inactivating this
population of neurons when CREB is first induced in them
profoundly impairs motor performance in both control (non-
stroke) and stroke mice, a result consistent with a role for CREB
in neuronal allocation of motor recovery. As a final test of the role
of CREB-transfected motor neurons in recovery, we performed a
washout study (Fig. 3h, i). Mice were first tested with CNO
induction and then tested again the next day, after CNO had
cleared. If CREB-transfected motor neurons are indeed causally
mediating recovery of motor performance, then CNO adminis-
tration should eliminate recovery of motor performance (see
above), and this recovery should re-emerge after CNO wash out.
This is indeed the pattern. Testing on weeks 5 and 11 in the same
animals in back to back days, first with CNO administered and
then with washout, shows that the recovered motor performance
that is induced by CREB is present without CNO, and is blocked
with CNO in individual animals (Fig. 3h, i). This experiment
means that motor recovery after stroke can literally be turned on
or turned off in the same animals.
CREB induction alters movement maps in motor cortex. If
CREB induction in motor cortical neurons drives recruitment of
these neurons into a larger cortical circuit that mediates recovery,
we hypothesized that CREB-transfected neurons after stroke
would control movement of greater body representations,
extending over more of the motor map, than similarly treated
neurons with a control virus. To test this hypothesis, we trans-
fected CREB plus channel rhodopsin (ChR2) in a column of
motor cortical neurons in the forelimb motor area (Fig. 4a). Blue
light activation drives action potential activity with this viral
construct (Fig. 4b). An optrode was used to activate this column
of motor cortex neurons at 4 weeks after stroke (Fig. 4c), the time
of motor recovery induced by CREB transfection. The number of
Fig. 2 Lentiviral CREB in peri-infarct motor enhances motor recovery. a Experimental timeline of behavioral studies. TAM taxomifen. b, d, f Gridwalking
tasks of forelimb function in gait. Y axis is percentage of footfaults of the right (affected) forelimb contralateral to the stroke. c, e, g Pasta handling task of
distal forelimb function. Y axis is the percentage of left forelimb adjustments (unaffected forepaw) relative to right forepaw (affected forepaw). b, c CREB
gain of function. Stroke+ CREB induction in motor cortex produced a significant recovery in forelimb function compared with stroke+ Control virus (***p
< 0.005) over 3–4 weeks after stroke, respectively in pasta handling adjustments and gridwalking. d, e Stroke+ CREB induction in posterior parietal cortex
did not produce recovery in forelimb function either in gridwalking or pasta handling over 8 weeks after stroke. f, g CREB loss of function. Activating CREBIR
with TAM 6 h before behavioral testing (stroke+ TAM) reduces motor control and blocks the pattern of motor recovery seen in stroke alone (Stroke+
Saline). *P < 0.05, **P < 0.01, ***P < 0.005. Error bars are SEM. Statistics are two way ANOVA followed by Bonferroni post hoc test. n= 8 for control virus
and stroke control virus; n= 10 for CREB and stroke CREB
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forelimb vs multi-joint movements was quantified. CREB
transfection in the forelimb area of normal (non-stroke) motor
cortex increases the number of body movements evoked by local
stimulation (Fig. 4d). Stroke causes a non-significant reduction in
evoked movements from the forelimb motor cortex stimulation
site. Stroke+ lenti-CREB/ChR2 causes a significant gain in multi-
joint movements compared with ChR2-stroke (Fig. 4d). These
movements localized to body parts outside of the forelimb, in the
CREB-induced mice, indicating that induction of CREB in motor
cortex with ChR2, compared to just ChR2-alone, allows activa-
tion of broader, or more extensive circuits than normally are
activated by the same neurons without CREB.
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CREB facilitates the reorganization of the sensory map. The
above data suggest that peri-infarct transfection of CREB accel-
erates recovery by increasing the recruitment of motor neurons
into a functionally active motor recovery network. CREB also
plays a key role in remapping of sensory functions in response to
altered afferent input, such as in somatosensory cortex after
whisker trimming27,28. During stroke recovery somatosensory
maps move into motor cortex29, a result that indicates that stroke
causes cortical remapping. It is possible that CREB affects this
cortical remapping process. To test this hypothesis, fore- and
hind-paw responses were mapped during stroke recovery
(Fig. 5a). CREB or control viruses were injected into motor cortex
as described above. In these studies, stroke was targeted to the
forelimb somatosensory cortex, which is associated with a shift in
forepaw representation into motor cortex during recovery.
Chronic intrinsic optical signal (IOS) imaging was performed in
the somatosensory cortex over 8 weeks after stroke (Fig. 5a, b). In
the normal cortex, stimulation of the contralateral forelimb (FL)
and hindlimb (HL) produces an IOS response in the somato-
sensory forelimb (sFL) and hindlimb (sHL) that is stable over
time (Fig. 5c, d). Stroke caused a loss in this sensory forelimb
response, which persisted over 4 weeks. Eight weeks after stroke,
forelimb stimulation evoked a weaker forepaw response in the
shifted region, including motor cortex and adjacent hindlimb
somatosensory cortex (Fig. 5c, d). This spatial shift of forelimb
somatosensory responses into motor cortex represents a sig-
nificant effect within the sensory map (Fig. 5d), and has been
previously reported29,30. No changes were observed to the hin-
dlimb map for all the groups at any time point in all the groups
(Supplementary Figs. 14, 15). IOS mapping of mice transfected
with lenti-CREB showed an early recovery of the sensory forelimb
map into the same position as the control forelimb somatosen-
sory response, with no shift toward the motor forelimb map
(mFL). This recovery with CREB occurs significantly faster
(2 weeks after stroke) and is stable (Fig. 5c, d). The remapped
representation of FL appeared in the same position as the control
FL somatosensory response, with no shift toward the mFL.
Importantly, the magnitude of the stroke was similar across
animals infected with CREB or control lentivirus, as measured by
laser speckle contrast microscopy (Supplementary Fig. 13). These
results indicate that CREB induction in motor cortex facilitates
the recovery of the sensory FL map after somatosensory stroke, by
accelerating the time course of remapping into motor cortex
(Fig. 5e). Sensorimotor recovery in humans is most significant
when movement and sensory representations recover in their
original or closely adjacent regions31. These data indicate that
increasing CREB levels in peri-infarct cortex after stroke,
establishes recovery in the appropriate somatosensory cortical
representation, a mechanism thought to be key for successful
recovery.
CREB overexpression after stroke produces axonal sprouting.
Stroke induces axonal sprouting within motor, pre-motor, and
somatosensory cortical areas, and these new connections are
correlated with functional motor recovery17–19,32. CREB drives
axonal growth from neurons over inhibitory substrates in spinal
cord33, suggesting that a mechanism for CREB action in motor
recovery after stroke may be through axonal sprouting in motor
circuits. The tracer BDA was microinjected into motor cortex
13 weeks after stroke, and animals were killed 1 week later
(Fig. 2a). Axonal sprouting is identified when a pattern of cortical
projections is precisely mapped, by digital tracing of each BDA-
labeled projection, and is statistically different across treatment
conditions16–19. The location of axonal connections in each
mouse cortical hemisphere was plotted, the digital maps of each
axonal projection were grouped by condition, and cortical pro-
jection maps were then quantitatively compared across treatment
groups (Hotelling’s t2 test) for overall differences in cortical
projections, and for specific areas that have a different pattern of
connections as previously described (Fig. 6a–g).
New connections in peri-infarct cortex in stroke can be
detected in both genetic approaches in delivery of CREB; in
particular we observed a significant increase in BDA-labeled
projections after stroke in motor cortex in lenti-CREB (n= 4,
Hotelling’s t2 test P < 0.021) mice with stroke when compared,
respectively, with their controls (CREB virus alone, Fig. 6c, d) or
with the control virus (control (non-CREB) virus plus stroke, P <
0.029) (Fig. 6e, f). Lenti-CREB alone in the normal, non-stroke
brain does not promote axonal sprouting (lenti-CREB alone vs
control virus: n= 4, P= 0.25, Fig. 6a, b). These data indicate that
induction of CREB in forelimb motor cortex produces axonal
sprouting, particularly in motor-to-premotor connections, a
pattern that is associated with functional recovery16–19.
CREB induces a distinct transcriptional profile after stroke.
CREB modulates synaptic plasticity by altering gene expression
and acts as a direct transactivator of regeneration-associated
genes to mediate axonal sprouting34. To identify the molecular
systems that are induced by CREB during behavioral recovery
after stroke, CREB-transfected or control pyramidal neurons
from motor cortex were FACS-isolated at the time of enhanced
motor recovery (4 weeks after stroke) in control (non-stroke) and
stroke conditions (Fig. 7a). RNA was isolated and used to probe
Fig. 3 hM4Di/CREB inhibition of cortical neurons after stroke blocks motor recovery. a Schematic shows the process by which DREADD hM4Di-CREB
when activated by CNO (30min before behavioral tasks) can lead to selective inactivation of neurons in motor cortex in which CREB is induced. b
Immunohistochemical staining in peri-infarct M1 in mice transfected with hM4Di-CREB/eGFP (green, infected cells) overlapping with NeuN staining
(purple) 4 weeks after stroke. Scale bar= 50 μm. Stereological quantification of motor cortex M1 CREB-induced cells (CREB-eGFP+ cells) relative to the
whole motor cortex (NeuN+ cells). c Stereological quantification of two immediate early genes, pCREB (phospho-CREB) and Zif268, in hM4Di/CREB-
induced neurons in M1 after CNO or Saline administration during pasta handling motor task. ** P < 0.05,***P < 0.005, one way ANOVA followed by
Bonferroni post hoc test n= 4. Eight brain sections for each mouse. d, f Gridwalking tasks of forelimb function in gait. Y axis is percentage of the number of
footfaults of the right (affected) forelimb contralateral to the stroke. e, g Pasta handling tasks. Y axis is the percentage of left forelimb adjustments
(unaffected forepaw) relative to right forepaw (stroke-affected forepaw). d, e CREB gain of function. In the absence of CNO, Stroke+ hM4Di-CREB
induction in peri-infarct M1 produces a significant recovery in forelimb function over 3–4 weeks after stroke, respectively in pasta handling adjustments and
gridwalking, as with studies in Fig. 2b, d. n= 13 for stroke CREB CNO, n= 10 for CREB, and n= 9 for stroke CREB. f, g Selective inactivation with hM4Di-
CREB of neurons in motor cortex (CNO administration) blocks motor recovery compared to mice with stroke+ control virus either in grid walking or in
pasta handling adjustments (**P < 0.05, ***P < 0.005, two way ANOVA followed by Bonferroni post hoc test). h, i Pasta handling graphs show motor
recovery induced by hM4Di-CREB induction in the same mice in the absence of CNO (washout, mice tested day after CNO administration) at 5 and
11 weeks after stroke. n= 12 for control virus CNO, n= 11 for CREB CNO, and n= 10 for stroke control virus CNO (h). i Individual animals in pasta handling
performance after CNO administration and after washout and 5 and 11 weeks after stroke. Gray bar shows the average performance of stroke-only mice,
taken from data in Fig. 1c–e
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whole genome arrays. To confirm this transcriptional profile,
FACS isolation and microarray analysis were performed sepa-
rately in the second cohort of Control Stroke and CREB Stroke
animals (termed Control Stroke “A” and “B” and CREB Stroke
“A” and “B”). Gene expression data were filtered to only include
those with a gene expression P-value threshold of <0.005 and a
minimum log2-transformed fold change of 0.2. Unsupervised
clustering of the 100 most differentially regulated genes in each
data set indicates that the condition with the greatest effect on
gene transcription is induction of CREB or exposure to stroke
(Fig. 7c): the transcriptional effect of CREB induction, stroke, and
stroke+ CREB drive the difference between transcriptomes in
neurons. To understand how CREB induction in cortical neurons
affects the normal transcriptional state induced by stroke, we
compared Control Stroke across the two cohorts to Stroke CREB
induction in the two cohorts. The transcriptional profile of
Control Stroke clusters most closely to the replication study of
Control Stroke, as expected (Fig. 7c). CREB induction in stroke
produces a distinct transcriptome, with both initial and replica-
tion runs of CREB Stroke neurons having a similar transcrip-
tional profile, and one that is distant from Control Stroke
(Fig. 7c). This indicates that CREB induces a very distinct
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Fig. 4 Lentiviral CREB expression induces greater multi-joint movements after stroke. a Immunohistochemical staining of pyramidal cells (CAMKIIα
promoter drives expression in pyramidal neurons) in peri-infarct M1 in mice transfected with Lentiviral ChR2-mCherry (left) and lentiviral CREB-eGFP
(middle). Right: Co-localization of ChR2 and CREB lentiviruses 4 weeks after stroke, showing nearly complete co-transfection with these two viruses. Scale
bar= 50 μm. bWhole cell recording shows a pyramidal cell (cortex) transfected with lenti-ChR2/mCherry. The cell displayed action potentials (AP) in cell
attached mode with blue light (4 mW) and tracked higher frequency light stimulation (10 Hz). At −70mV, blue light (4 mW, 0.5 ms pulse) triggers an
inward current as expected. c Setup of head-fixed mouse allowed to run freely on a floating Styrofoam ball to detect multi-joint movements during brief
pulses of blue light stimulation (pulse length 5ms, pulse frequency 20 Hz). d Graph shows the percentage of multi-joint complex movements during light
stimulation. Stroke+ ChR2-CREB produced a significant increase in multi-joint movements compared with stroke+ ChR2-alone 4 weeks after stroke
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transcriptome within the condition of stroke as compared to
inducing CREB in cortical neurons in the control state. In total,
205 genes were differentially expressed between CREB alone vs
Control alone (90 up-regulated and 115 down-regulated genes, P
value < 0.005) and 1104 genes were differentially expressed
between Stroke CREB vs Stroke Control virus (552 up- and 552
down-regulated genes, P value < 0.005) (Fig. 7b). Gene ontology
analysis in Stroke Control vs Stroke CREB shows that CREB
induction in stroke activates sets of genes within cellular path-
ways that are relevant to neural repair and recovery, including
nervous system development, tissue development and organismal
development (Fig. 7d).
To identify specific molecular targets of CREB induction
during the period of behavioral recovery after stroke, we analyzed
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the significantly regulated genes in the Stroke CREB transcrip-
tome for co-regulated molecular pathways with known
protein–protein interactions (Fig. 7e). CREB induction in stroke
differentially regulates a distributed network of genes with roles in
neuronal plasticity or recovery after stroke, including induction of
the obligatory NMDA receptor subunit 135 FGF, GDNF, and GH
and their receptors36; the transcription factor Sox237; Proto-
cadherin 138 and the calcium-binding proteins, calneuron 139,
and calcium-dependent secretion activator 240. As CREB is a
universally expressed transcription factor, these genes that are
selectively regulated in cortical neurons in Stroke+ CREB
identify molecular targets for a more specific pharmacology to
promote stroke recovery, in addition to an approach of targeting
isoforms of CREB-modulating enzymes that are uniquely
expressed in stroke-affected brain regions, such as phosphodies-
terase inhibitors41.
Discussion
The main findings of this study are: 1. Lentiviral CREB trans-
fection in motor neurons anterior to the stroke site enhances
recovery of the motor deficit. 2. This region of motor cortex is the
same area in which axonal sprouting in motor and premotor
circuits after stroke mediate recovery17,18, and in which a CREB-
induced gene product, BDNF, is necessary for motor recovery20.
3. This CREB effect is specific to this small pool of neurons in
motor cortex near the stroke site, as CREB induction in other
regions of peri-infarct tissue does not alter recovery. 4. Blockade
of CREB signaling inhibits normal motor performance after
stroke. 5. Remarkably, inducibly and reversibly inactivating
CREB-transfected motor neurons turns on and off motor
recovery. 6. CREB induction accelerates the remapping of lost
cortical sensory maps after stroke, with a timeline that matches
that of accelerated functional recovery. 7. As a transcription
factor, CREB in stroke activates a unique transcriptome of genes
that play a role in neuronal excitability and developmental neu-
ronal plasticity, establishing possible molecular mechanisms for
the CREB effect in motor recovery.
Much of the focus of CREB signaling studies in stroke has been
on the initial stages of ischemic cell death42,43. Later in stroke,
there is no detectable difference in CREB activation in the reco-
vering brain after stroke and the control, non-stroke brain44.
pCREB and CRE-induced gene expression are seen with a max-
imum in the first 2 days after stroke45, although CREB activation
can be detected in glial cells for weeks after stroke, where it has a
role in neurogenesis and gliogenesis46,47. The present data indi-
cate that treatments that activate CREB after the period of cell
death may provide a target for a neural repair therapy in stroke.
The present findings have two important implications in the
motor circuit control of recovery after stroke. First, motor
recovery after stroke can be produced by modulating CREB sig-
naling in a small pool of motor cortical neurons near the stroke
site. This finding that CREB induction in a small subset of a brain
circuit will change function of that circuit is supported by the
effect of CREB in memory paradigms. During fear conditioning,
roughly 70% of neurons in the lateral amygdala receive sensory
inputs, but only about one-quarter exhibit learning-related
synaptic plasticity48–50. CREB manipulation in approximately
20% of lateral amygdala neurons is sufficient to influence fear
conditioning. In the present study, lentiviral transduction of
CREB in ~9000 neurons, roughly 16% of the total motor cortex, is
sufficient to induce motor recovery after stroke. This finding is
the first to identify a specific motor circuit for recovery after
stroke. How does this finding relate to the neuronal network
architecture for movement control and does CREB activation
expand a functional motor circuit for forelimb movement? In
spontaneous limb movements, motor cortex is grouped into
microcircuits of neurons with highly correlated activity that span
100 µm51, and with the same distance (70 µm) with a trained
forelimb task52,53. In a different circuit measure, motor cortex
input comes from within the local cortical circuitry and this has
been estimated at 500 µm54. With this microcircuitry in mind, the
lentivirus approach clearly transfects CREB in a large number of
movement related motor cortex microcircuits. However, a key
point from the present data is that, within these microcircuits,
CREB transforms their function into a dominant role, such that
inhibiting them significantly diminishes motor output to the
contralateral forelimb, which does not occur if these circuits are
inhibited but CREB is not induced.
A second implication of the present findings in motor net-
works for stroke recovery is that CREB transfection appears to
disproportionally commit motor cortical neurons into a network
for movement control both in normal brain and with a much
larger effect after stroke. This is supported by three findings. First,
CREB-transfected neurons are more likely to be activated in
expressing immediate early genes during movement than neurons
transduced with the same virus without CREB. Second, CREB-
transfected motor cortical neurons in the motor forelimb area
after stroke are more likely to activate body movements outside of
that forelimb area. Third, acute inactivation of CREB-transfected
motor cortical neurons produces motor control deficits, whereas
acute inactivation of these neurons without CREB does not. This
inactivation finding is distinct between control (non-stroke) and
stroke. In the control (non-stroke) brain, inactivation of CREB-
induced neurons in forelimb motor cortex impairs motor control
but inactivation of a similar-sized pool of motor cortical neurons
without CREB transfection does not impair motor control. In
stroke, inactivation of CREB-transfected motor cortical neurons
not only impairs motor control, as seen in the control (non-
stroke) brain, but does so in a truly substantial way with a dou-
bling of the stroke deficits, particularly in gait. Inactivation of
motor cortical neurons after stroke that have not been transfected
with CREB does not produce motor deficits on top of those of the
stroke itself. For comparison, inactivation of CREB-transfected
neurons has a much greater effect on memory recall than inac-
tivation of a similar number of neurons that do not have CREB
transfection9,55. These parallels between neuronal network
alteration with CREB induction in motor cortex and in memory
systems in the amygdala support a general role of CREB in
committing neurons into an active circuit—in the impaired
Fig. 6 Quantitative mapping of motor system connections after stroke and with CREB induction. a, c, e Each map represents all of the digitally mapped
connections from all the animals in each condition (n= 4 for each condition) from M1 anterior to the stroke site, collapsed onto a representative tangential
section through the mouse cortical hemisphere. The Y and X axes show mm distance from the center of the tracer injection site. The dark blobs on the
maps are the location of the primary somatosensory vibrissal field (the “barrel” field). Light blue label corresponds to the condition in the light blue labeled
text at the top of each panel; red corresponds to the condition in the red label at the top of each panel; and dark blue is dense overlap. b, d, f In polar plots of
connections of forelimb motor cortex projections the plot is made relative to the tracer injection in forelimb motor cortex as the origin. Each filled polygon
(blue and red) is the 70th percentile of the distances of all BDA-labeled connections from the injection site in each segment of the graph. The lines in these
plots are the median vector of that segment of the plot, multiplied by the median of the normal distribution of the number of points in a given segment of
the graph. P value is Hotelling's T2. g Schematic summary of axonal sprouting after stroke with CREB induction
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motor control after stroke and in the memory trace during a
learning task.
These studies in stroke support a concept of two levels of
plasticity in motor cortex: CREB-induced plasticity and Stroke-
induced plasticity. In the first, the transcriptional effect of CREB
allows a population of neurons in a region of motor cortex to
exert greater control in movement of the body part represented in
that network. This cortical circuit-capturing effect of CREB even
in the normal brain could be done by increasing the number of
neurons in a movement-associated ensemble56 or by increasing
the correlated firing activity in the same ensemble57. Inactivation
of CREB-transfected neurons in the normal brain in this first level
of circuit plasticity produces a deficit in normal motor control—
interestingly one that is equivalent in magnitude to that produced
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Fig. 7 CREB-stroke transcriptome in motor cortex during period of recovery. a Fluorescence-activated cell sorting (FACS) isolation of CREB-transfected or
control neurons in motor cortex after stroke. In the scattergrams, each selected cell is indicated by a dot. The cluster of sorted neurons (cells in the gate) in
the scattergram corresponds to neurons that were selected for further analyses of their fluorescence characteristics. GFP-positive (CREB-transfected) or
GFP-/Texas Red-positive cells (control virus, tdtomato-eGFP) with high fluorescence levels are displayed in a fluorescence scattergram where FSC
(forward scatter light) represents the absorbance of transmitted laser light for each neuron and SSC (side scatter light) the light scattered at a 90-degree
angle. b Hypergeometric overlap of genes that are significantly induced in control motor cortex neurons with CREB transfection compared to normal, non-
transfected neurons that overlap with CREB-transfected neurons after stroke compared to non-transfected neurons after stroke. Red: upregulation; green:
downregulation. There is little overlap of the two transcriptomes. c Unsupervised clustering of top 100 differentially expressed genes at P < 0.005. Z score
is indicated by top right inset. d Top regulated canonical pathways in Stroke+ CREB vs Stroke. Middle column shows the inverse log of the P value
corrected for multiple comparisons in Benjamini–Hochberg (B–H) test. The left column shows the number of significantly regulated genes in the Stroke-
CREB transcriptome that are within this canonical pathway. eMolecular pathway analysis showing interactions between significantly regulated genes in the
Stroke-CREB transcriptome. Red is upregulated with darker indicating greater fold change. Downregulation is in green with same color strength scheme.
Log2 fold change is below each gene
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by stroke. In the second level of plasticity, stroke itself opens up
plasticity and a process of change in cortical maps27,28, and
CREB-induced neurons build on the post-stroke plastic state to
drive control of even more of the motor cortical circuit. In this
post-stroke state, inactivation of CREB-transfected neurons more
profoundly impairs motor control—much more than stroke
alone. The mechanisms for the first level of plasticity—CREB-
induced plasticity—are likely the CREB-produced changes in
cellular excitability and preferential commitment of CREB neu-
rons into a motor circuit, as in memory systems10–12. The
mechanisms for the second level of Stroke-induced plasticity are
not clear, but several excitability changes occur in this region of
peri-infarct cortex. Tonic GABA signaling is increased8,9, which
depresses pyramidal neuron excitability. This may provide for a
greater delta in the excitability increase with CREB and in sec-
ondary synaptic integration of a CREB-transfected neuron.
Excitatory signaling through the AMPA receptor in this region of
peri-infarct cortex shows enhanced sensitivity to the induction of
BDNF20, suggesting that a further CREB-induced increase in
neuronal excitability might result in even greater downstream
plasticity effects. As noted, motor cortical neurons that control a
voluntary limb movement after stroke form functional clusters
that are likely the basis for CREB-induced plasticity and Stroke-
induced plasticity.
Expression of dominant-negative CREB in the primary visual
cortex prevents ocular dominance plasticity, suggesting that
CREB function may underlie the competitive interaction
responsible for axonal territory assignment in the developing
visual system13,14. CREB is necessary for the experience-
dependent plasticity that underlies cortical responses to periph-
eral lesions in the somatosensory cortex27. The present data
indicate that CREB also plays a role in the plastic remapping of
cortical representations after stroke. Stroke damage eliminates the
somatosensory body map, which then reforms after a 4-week
delay in adjacent motor and ectopic somatosensory regions29,32.
CREB induction accelerates the timeline during which injured
cortex can remap somatosensory representations and the nature
of this remapping: the forepaw somatosensory cortex is remapped
in very close proximity to its original location (Fig. 5d). This
pattern of remapping also matches the distribution of axonal
projections in peri-infarct cortex (Fig. 6b, d, f). In human stroke,
remapping of sensorimotor functions into sites close to their
original location is associated with greater recovery31. Just as
CREB plays a key role in regulating visual cortex allocation of
eye-specific inputs, the present data indicate that after stroke
CREB plays a key role in regulating somatosensory allocation of
limb-specific inputs during recovery.
Methods
Animals. All procedures were performed under an NIH approved animal protocol
and the University of California Los Angeles Chancellor’s Animal Research
Committee. 2–4 month-old adult C57BL/6 (Charles River and Jackson Lab) or
LBD-CREB male mice23 were maintained on a 12 h light/dark cycle with free access
to food and water.
Photothrombotic model of focal cortical stroke. Under isoflurane anesthesia
(2–2.5% in a 70% N2O/30% O2 mixture), mice were placed in a stereotactic
apparatus, the skull exposed through a midline incision, cleared of connective
tissue and dried. A cold light source (KL1500 LCD, Carl Zeiss MicroImaging, Inc.)
attached to a 40× objective giving a 2-mm diameter illumination was positioned
1.5 mm lateral from Bregma, and 0.2 ml of Rose Bengal solution (Sigma; 10 g l−1 in
normal saline, i.p.) was administered. After 5 min, the brain was illuminated
through the intact skull for 15 min16–20.
Model of combined cortical, subcortical white matter, and striatal stroke. The
above procedure for photothrombotic stroke was followed. A 10 min illumination
through the skull was followed by ipsilateral carotid ligation and 2 µl injection of
the vasoconstrictor N5-(1-Iminoethyl)-L-ornithine (L-NIO; 27 mg/ml in sterile
physiological saline; EMD Millipore) into the striatum (A/P 0.00, M/L 3.00, D/V
2.60; at 10o). After completion of the L-NIO injection the needle was withdrawn.
To assess the size and location of this cortical/subcortical stroke, three mice were
euthanized at 2 days post-stroke and processed for TTC staining.
Cresyl violet stain. Cresyl violet stain was performed by immersing sections in 50,
70, 95, and 100% ethanol for 1 min each followed by 45 min immersion in 50%
ethanol/50% chloroform. Slides were then immersed back through the 100, 95, 70,
and 50% ethanol and rinsed in distilled water before being stained in cresyl violet
solution for 45 s. Slides were rinsed in distilled water and dehydrated in 95 and
100% ethanol before being placed in xylenes and coverslipped.
Infarct size analysis. Cresyl violet-stained sections from behavior-tested animals
were imaged using a confocal microscope (Nikon C2). Cortical and hemispheric
areas were traced using ImageJ (NIH). Percent cortical loss was measured by
dividing ipsilateral cortex area by contralateral cortex area. Data was analyzed
using a paired t-test.
Lentivirus injection. Lentivirus injections were performed immediately after stroke
(Fig. 1a). For the gain of function studies, we transfected the peri-infarct motor
cortex of WT mice (anterior to the stroke lesion) with 1.5 µl of lentivirus that
overexpress CREB (CamkIIa_HA_AlstR_F2A_EGFP/CREB) or the control lenti-
virus (CamkIIa_HA_AlstR_ F2A_EGFP/dTomato) in two different points (M/L:
−1.5 mm, A/P: 1.0 and 1.5 mm, D/V: 0.75 mm) or we transfected the lenti-CREB
immediately posterior (M/L: −1.5 mm, A/P: −2.1 mm, D/V: 0.75 mm) to the
stroke lesion (PTLp22).
For the selective loss of function study, we transfected the peri-lesion motor
cortex of mice with 1.5 µl of hM4Di-CREB (CamkIIa_HA/hM4Di_T2A_EGFP/
CREB) or the control lentivirus (CamkIIa_HA/hM4Di_T2A_EGFP/dTomato)24 in
the same area of the motor cortex (anterior to the stroke lesion; M/L: −1.5 mm,
A/P: 1.0 and 1.5 mm, D/V: 0.75 mm).
Tamoxifen administration. For the loss of function studies, groups of LBD-CREB
mice were administered with TAM (16mg/kg i.p., Sigma #T5648) or vehicle
(similar volume of 0.9% saline solution) 6 h before behavioral tasks23.
CNO administration. For the selective loss of function study, groups of C57BL/6
mice were administered with CNO (0.3 mg/kg i.p., Biomol International) or vehicle
(similar volume of 0.9% saline solution) 30 min before each behavioral task.
Behavioral assessment. Mice (8–10 per group) were tested on the grid-walking,
cylinder, and capellini tasks, 1 week before surgery to establish baseline perfor-
mance levels17,18,20,21. For the capellini task, mice were trained for a period of
2 weeks and subsequently animals were tested on weeks 1, 3, 5, 7, and 11 after
stroke (Figs. 2–3; Supplementary Figs. 5–7, 9). Behaviors were scored by observers
who were blind to the treatment or experimental group. These behavioral tests rely
on a degree of exploratory behavior and novelty; more frequent testing than every
3 weeks (grid and cylinder) or 2 weeks (pasta handling) produces acclimation and
lack of movement.
Immediate early gene quantification. Mice received stroke and either (Cam-
kIIa_HA_AlstR_F2A_EGFP/CREB) or the control lentivirus (CamkIIa_-
HA_AlstR_ F2A_EGFP/dTomato). Four weeks later, mice were euthanized,
perfused with 4% paraformaldehyde, and the brains isolated and post-fixed over-
night. 50 μm sections were cut and collected at every 200 μm intervals and stained
immunohistochemically for phosphoCREB (pCREB, antibody source) or Zif268.
Images were collected at 20× (Nikon C2 confocal) and co-localization of green
fluorescence with red fluorescence used to visualize NeuN or red fluorescence in
control virus and green fluorescence used to visualize NeuN was counted. Data was
analyzed using a paired t-test.
Electrophysiological recording and stimulation. Mice were deeply anesthetized
with isoflurane and perfused with ice-cold high sucrose solution containing the
following (in mM): 280 sucrose, 2.5 KCl, 1.25 NaH2PO4, 26 NaHCO3, 1.3 MgCl2, 8
MgSO4, and 10 glucose. Coronal slices (300 μm) were obtained using a microslicer
(Leica VT1000S; Leica Microsystems) and transferred to an incubating chamber
containing ACSF (130 NaCl, 3 KCl, 1.25 NaH2PO4, 26 NaHCO3, 2 MgCl2, 2 CaCl2,
and 10 glucose) oxygenated with 95%O2–5%CO2 (pH 7.2–7.4, 290–310 mOsm).
The slices were incubated for 40 min at 32 °C and more 20 min at room tem-
perature. Pyramidal cells were visualized with a microscope (Olympus BX51WI),
which was equipped with differential interference contrast optics and fluorescence.
The recordings were obtained using a MultiClamp 700B Amplifier (Molecular
Devices) and pCLAMP 10.5. The patch pipette (3–4MΩ impedance) contained a
Cesium methanesulfonate-based internal solution (in mM): 130 Cs-methane-
sulfonate, 10 CsCl, 4 NaCl, 1 MgCl2, 5 MgATP, 5 EGTA, 10 HEPES, 5 GTP, 10
phosphocreatine, and 0.1 leupeptin. In cell attached mode, blue light stimulation
(CooLED, 473 nm, 4 mW) was used to activate ChR2-expressing neurons. The blue
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light (CooLED, 473 nm, 4 mW) evoked action potentials in the recorded cells.
Yellow light (CooLED, 572 nm, 20 mW) did not trigger any response in the same
cells (data not shown). The whole-cell patch-clamp recordings were done in voltage
clamp mode. AMPA and NMDA receptor antagonists (NBQX 10 μM, APV 50 µM,
Sigma) were added to the external solution.
In vivo optogenetic stimulation of the motor cortex. Under isoflurane anesthesia
immediately after stroke suspension of two lentiviruses, Lenti-CREB (1 μl) and
Lenti-ChR2 (1 μl), were injected stereotaxically in the motor cortex M1 of C57BL/6
male mice in each condition (n= 5 Lenti-ChR2 control, n= 5 stroke plus Lenti-
ChR2, n= 4 Lenti-CREB+ Lenti-ChR2, and n= 4 stroke plus Lenti-CREB and
lenti-ChR2). The injection coordinates were 1.5mm lateral, 1 and 1.5 mm anterior,
and 0.75 mm ventral to the Bregma. An optrode (250 micron core, fiber length 0.5
mm with 10% of light pass by, UCLA Behavioral Testing Core) was positioned
stereotaxically between the two injections sites (M/L: −1.5mm, A/P: 1.25 mm, D/V:
0.5mm). Titanium head bar was attached to the skull using a layer of dental cement.
Over the next week, mice were head-fixed when awake and trained on a free-
floating foam ball before optogenetic stimulation. Four weeks after stroke and
lentiviruses injection, mice were videotaped and blue light-stimulated (λ= 473 nm)
for 10 s (pulse length 5ms, pulse frequency 20 Hz). The number of multi-joint
movements (forelimb movements+mouse-wisker-trunk movements) was quanti-
fied (Fig. 4). A trunk movement is when the animal engages in a lateral or torsional
movement of the axial musculature between the upper and lower extremity.
Intrinsic optical signaling imaging. Chronic glass-covered cranial windows were
implanted16. Briefly, mice were anesthetized with isoflurane (1.5% via nose cone)
and placed in a stereotaxic frame over a warm water re-circulating blanket. Dex-
amethasone (0.2 mg/kg; Baxter Healthcare Corp.) and carprofen (5 mg/kg; Pfizer)
were administered subcutaneously to reduce brain edema and local tissue
inflammation. A 4mm craniotomy was performed with a pneumatic dental drill.
The center of the craniotomy was placed of over the left hemisphere, 3 mm lateral
to the midline and 1.7 mm caudal to Bregma. A sterile 5 mm glass coverslip
(Electron Microscopy Sciences) was gently laid over the dura mater and glued to
the skull with cyanoacrylate-based glue. Dental acrylic was then applied throughout
the skull surface. A titanium bar (0.125 × 0.375 × 0.05 inch) was embedded in the
dental acrylic to secure the mouse on to the stage for imaging. Virus injection was
carried out right after the opening of the skull (Fig. 5).
IOS imaging of the FP and HP sensory receptive fields was done at different
intervals before and after RBPT stroke (control, 1 week, 2 weeks, 4 weeks, and
8 weeks). IOS imaging was performed through the cranial window on mice under
light anesthesia with 0.5–0.75% isoflurane and a single dose of chlorprothixene (6mg/
kg, i.p., Sigma-Aldrich). The cortical surface was illuminated by green (535 nm) and
red (630 nm) sets of light-emitting diodes (LEDs) mounted around a “front-to-front”
tandem arrangement of objective lenses (135mm and 50mm focal lengths, Nikon).
The green LEDs were used to visualize the superficial vasculature and the red LEDs
were used for IOS imaging. The microscope was focused to ~350 µm below the
cortical surface. Imaging was performed at 10 frames per second using a fast camera
(Pantera 1M60, Dalsa), frame grabber (64 Xcelera-CL PX4, Dalsa) and custom
routines written in MATLAB. Each session consisted on 30 trials, taken 20 s apart, of
mechanical stimulation for 1.5 s (100Hz) using a glass micropipette (blunt tip for)
coupled to a piezo bender actuator (Physik Instruments). Frames 0.9 s before onset of
stimulation (baseline) and 1.5 s after stimulation (response) were collected. Frames
were binned three times temporally and 2 × 2 spatially. Stimulated cortical areas were
identified by dividing the response signal by the averaged baseline signal (DR/R) for
every trial and then summing all trials. Response maps were then thresholded at 50%
of maximum response to get the responsive cortical areas for FP and HP. For figures,
we aligned the response maps for FP and HP stimulation within and across animals
for all time points (pre-stroke,+1 week,+2 weeks,+4 weeks, and+8 weeks) with the
help of the corresponding photomicrographs of the superficial vasculature. To
generate the final image, we merged and color-coded the responses for FP and HP
(green and red, respectively) for every time point into a single RGB image in Adobe
Photoshop (Adobe Systems Inc.) (Fig. 5; Supplementary Figs. 10, 11).
Laser speckle contrast microscopy of cerebral blood flow. The cortical surface
was illuminated with an expanded laser diode beam (785 nm, 80 mW, Thorlabs
Inc.) coupled to a 600 µm diameter fiber optic cable (Thorlabs Inc.). Sequences of
100 images were acquired at 30 frames per second using a fast camera (Pantera
1M60, Dalsa) with 1024 × 1024 pixels yielding images of 3.25 × 3.25 mm2. Speckle
contrast images (K= standard deviation/mean, 5 × 5 pixel area, 3.15 µm/pixel) for
every frame were obtained and averaged over the 100 frames using a custom
written ImageJ plugin (courtesy of Timothy Murphy, University of British
Columbia, Vancouver, Canada). Relative cortical blood flow values were obtained
as the ratio K02/Kt2 (Supplementary Fig. 12).
BDA injection. For the stereological quantification of axonal sprouting, 12 week
post-stroke animals were injected with the neuroanatomical tracer 10% biotiny-
lated dextran amine (300 nl of BDA; 10,000MW; Invitrogen) in the same position
of lentivirus injection (M/L: −1.5 mm, A/P: 1.0 and 1.5 mm, D/V: 0.75 mm). One
week later, mice were sacrificed and brains were sliced tangentially (40 μm)16–19.
BDA was visualized in the same sections using the Standard Vectastain Elite Kit
(Vector Labs) and the chromogen diaminobenzamidine.
Quantification of axonal sprouting. Axonal sprouting was quantified as pre-
viously described16–19. Briefly, axonal sprouting (n= 4 animals per each condition:
Control virus, stroke control virus, CREB, and stroke CREB) was quantified by
digitally marking each BDA-positive process in the superficial layers of the cortex
(layers 2/3 and 4) using a microscope system (Leica Microsystems) and analysis
program (Stereoinvestigator, MBF Biosciences). BDA-positive processes were
marked x/y coordinates relative to the center of the injection site by an observer
blinded to the treatment conditions. This process generates an x,y plot of the
location of all labeled axons in each brain section. The x/y axonal plots from each
brain were registered with respect to the injection site and co-registered with
functionally relevant anatomical regions, produced by the staining of the mouse
somatosensory body map in cytochrome oxidase, to generate a composite pro-
jection map for each treatment condition. Custom software produces quantitative
connectional maps that consist of pixels, with the number of axons in each pixel
mapped in register with anatomical brain structures. Polar plots were constructed
with the x,y position of each BDA-labeled element plotted in relation to the tracer
injection in forelimb motor cortex as the origin. This polar mapping shows both
location and direction of axonal label. Scatter plots and polar maps were analyzed
for statistically significant differences in connectional profiles between treatment
groups using Hotelling’s t2 test for spatial correlation16–19 (Fig. 6).
Axonal sprouting was analyzed in two cohorts, using the Lenti-CREB and
Lenti-control viruses in stroke and control conditions and in a second independent
study using the DREADD viruses (n= 5 animals per each condition: hM4Di/CREB
plus saline, stroke hM4Di/CREB plus saline, hM4Di/CREB plus CNO, stroke
hM4Di/CREB plus CNO, hM4Di virus plus CNO, and stroke hM4Di plus CNO).
Isolation of neurons for fluorescence-activated cell sorting. Four-month-old
male C57BL/6 mice were anesthetized with isoflurane, decapitated, and cortical
tissue removed from underlying white matter. We used the same lentivirus from
the gain of function study for lenti-CREB (CamkIIa_HA_AlstR_F2A_EGFP/
CREB) and lentivirus control (CamkIIa_HA_AlstR_F2A _EGFP/tdTomato). We
performed FACS isolations on two different cohorts of mice to examine cell-type-
specific gene expression in mouse brain tissue. In the first study, we isolated eGFP
+ cells (CREB-transfected neurons) or eGFP/tdTomato+ cells (Control virus
transfected neurons) from a pool of three cortices of each treatment condition,
following 4 weeks after stroke and lentivirus injection (samples: n= 2 for stroke
control virus referred as Control Stroke A1 and A2, n= 2 for stroke CREB referred
as CREB Stroke A1 and A2, n= 2 for control virus referred as Control1 and
Control2, n= 2 for control CREB referred as CREB1 and CREB2) (Fig. 7c). In the
second study, we isolated eGFP+ cells or eGFP/tdTomato+ cells from a pool of
three cortices, 4 weeks after stroke and viral transfection, from stroke control virus
(n= 4 samples; Control Stroke B1–B4) and stroke CREB (n= 4 samples, CREB
stroke B1–B4) (Fig. 7c). Consequently, these two different cohorts of FACS-isolated
neurons were used to generate double-stranded DNA for two different Mouse Ref 8
v 2.0 Gene Expression chip (Illumina) (Fig. 7c). Peri-lesion cortices area corre-
sponding to the lentiviral injection site (1 mm2, anterior to the stroke site) from
control or stroked-mice (CREB-transfected, stroke CREB-transfected, control virus
transfected, or stroke control virus transfected; 4 weeks after lentivirus injection
and stroke) were dissected using a scalpel. Cortical tissue was enzymatically
digested and triturated20. Briefly, cortical tissue was equilibrated for 8 min and
digested for 30 min at 30 °C and 190 r.p.m. in 6 ml of papain solution (12 mg per
ml). Complete Hibernate buffer (Brainbits) was used to maintain neural metabo-
lites and pH during tissue dissection and digestion. Tissue was triturated into 6 ml
of suspension and loaded onto density gradient column (4 ml of 12.4% OptiPrep in
Hibernate), and centrifuged for 15 min at 900×g at 22 °C. The bottom 5ml was
collected and washed twice at 400×g for 5 min. Three cortices were pooled for each
group (stroke control virus, stroke CREB, control virus, and control CREB) for
FACS analysis (Fig. 7). Samples were maintained on ice during FACS isolation.
APC sort gates were set using positive and negative controls before neuron sorting.
Neurons were collected via FACS (FACsARIA, Becton Dickinson, UCLA FACS
Core) directly into 400 μl of lysis buffer for RNA isolation. Total RNA was
extracted using RNA-Microprep kit (Zymo-Research) and eluted into 7 μl ddH2O.
RNA quality was verified (RIN > 7) on an Agilent Bioanalyzer.
RNA preparation and array hybridization. Total RNA from FACS-isolated cells
from each group was pre-amplified and converted into double-stranded DNA
using Ovation PicoSL WTA System v2 (Nugen Technology) and biotinylated using
Encore BiotinIL Module (Nugen Technology) prior hybridization (UCLA Neu-
roscience Genomic Core, UNGC) on Mouse Ref 8 v 2.0 Gene Expression chip
(Illumina) according with Nugen Technology protocol.
Microarray analysis. Raw data were analyzed using the EdgeR Bioconductor
package54, and differentially expressed genes were classified according to gene
ontology based on a P value, P < 0.005. Differentially expressed genes were ana-
lyzed by molecular pathway analysis and canonical signaling systems using Inge-
nuity Pathway Analysis software (IPA, Ingenuity Systems) (Fig. 7). We performed
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two separate FACS isolations and microarray analysis from different cohorts of
mice. In the first study, we pooled three cortices for each condition following
4 weeks after stroke (n= 2 for stroke control virus, n= 2 for stroke CREB, n= 2
for control virus, and n= 2 for control CREB) (Fig. 7). In the second study, we
pooled three brains for each condition (n= 4 for stroke control virus and n= 4 for
stroke CREB). No differences were observed between the two studies.
Histology. One week after stroke and/or lentiviral injection, mice were killed by
transcardial perfusion with 4% paraformaldehyde in 0.1M phosphate buffer (pH
7.4, wt/vol). Brains were postfixed in 4% paraformaldehyde overnight, cryoprotected
in 20% sucrose, frozen, and sliced coronally (40 μm). A series of sections 200 μm
apart was incubated with NeuN (to label neurons, 1:100, Millipore, #MAB377),
GAD67 (to label inhibitory neurons, 1:800, Millipore, #C265), GFAP (to label
astrocytes, 1:1000, ThermoFisher Scientific, #13–0300), and Glucose Transporter-1
(Glut-1, to label blood vessels, 1:1000, Millipore, #400060) (Fig. 1; Supplementary
Figs. 2–4). Free-floating sections were rinsed, blocked in 3% normal donkey serum
and 0.3% Triton for 1 h, incubated in primary antibody in 3% normal donkey serum
and 0.1% Triton overnight at 4 °C, rinsed, incubated in secondary antibody [Dylight
488F(ab)2 or Dylight 597F(ab)2 anti-rabbit, anti-rat, or anti-mouse; Jackson
Immunoresearch] in 0.1% Triton for 1 h, rinsed, mounted, and cover-slipped.
Imaging was performed using a Nikon C2 confocal laser scanning microscope. The
images were taken using a 20× and 60× objectives. The total number of CREB/
eGFP-positive cells in the peri lesions motor cortex was counted across at least six
sections from comparable antero-posterior levels from each mouse. The percentage
of CREB/eGFP-positive cells was calculated as the percentage of CREB/eGFP-
positive cell per total NeuN-labeled cells in the motor cortex.
For the immediate early gene study (Fig. 3), 4 weeks after lentiviral injection
brains were sliced coronally (40 μm) and incubated with Zif268 (Zinc finger
protein 225 or erg-1; 1:750, Cell Signaling, #4153S) or p-CREB (phospho-CREB,
1:800, Cell Signaling, #9198).
Automatic counting in multiple fluorescent images was performed using ImageJ
software, version 1.4 (National Institutes of Health). Statistical analysis was
performed using paired two-tailed Student t tests.
Statistical analysis. Mice were randomly allocated to treatment condition using a
randomized block experimental design (restricted randomization) and all results
were analyzed with the investigator blinded to treatment condition. No animals
were excluded from analyses. Differences between two means were assessed by
unpaired two-tailed Student’s t test. Data from behavioral experiments were ana-
lyzed by two-way repeated-measures ANOVA followed by Bonferroni’s post hoc
test. Data from the optogenetic study were analyzed by multiple comparisons 1
ANOVA followed by Kruskal–Wallis’s test. All statistical analyses were performed
with GraphPad Prism version 6 (GraphPad Software). The level of statistical sig-
nificance was set at P < 0.05. All data are expressed as mean ± SEM. Sample size in
tissue outcome and behavioral studies was assessed by power analysis using a
significance level of α= 0.05 with 80% power to detect differences in ANOVA.
Animal number in in vivo quantitative cortical mapping studies utilizes spatial
correlation statistics, so sample size was estimated from previous publications with
similar mechanistic studies16–20. Scatter plots were analyzed using Hotelling’s t2
test for spatial correlation16–20.
Data availability. The datasets generated during and/or analyzed during the
current study are available from the corresponding author on reasonable request.
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